Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.40
0.042.94%
At close: Jul 2, 5:00 PM EST
$1.46
0.064.29%
After Hours: 7:01 PM EST
VolitionRX Ltd Analyst Ratings
VNRXAMEX
VolitionRX Analyst Ratings and Price Targets | AMEX:VNRX | Benzinga
VolitionRX Ltd has a consensus price target of $2.94 based on the ratings of 10 analysts. The high is $5 issued by EF Hutton on November 1, 2024. The low is $1 issued by HC Wainwright & Co. on April 2, 2026. The 3 most-recent analyst ratings were released by Maxim Group, HC Wainwright & Co., and D. Boral Capital on June 18, 2026, April 2, 2026, and March 31, 2026, respectively. With an average price target of $2.67 between Maxim Group, HC Wainwright & Co., and D. Boral Capital, there's an implied 82.65% upside for VolitionRX Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
HC Wainwright & Co.
Freedom Broker
Jones Trading
EF Hutton
1calculated from analyst ratings
Analyst Ratings for VolitionRX
Loading calendar...
FAQ
What is the target price for VolitionRX (VNRX) stock?
The latest price target for VolitionRX (AMEX:VNRX) was reported by Maxim Group on June 18, 2026. The analyst firm set a price target for $4.00 expecting VNRX to rise to within 12 months (a possible 173.97% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VolitionRX (VNRX)?
The latest analyst rating for VolitionRX (AMEX:VNRX) was provided by Maxim Group, and VolitionRX their buy rating.
When was the last upgrade for VolitionRX (VNRX)?
There is no last upgrade for VolitionRX
When was the last downgrade for VolitionRX (VNRX)?
The last downgrade for VolitionRX Ltd happened on April 20, 2026 when D. Boral Capital changed their price target from N/A to N/A for VolitionRX Ltd.
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on June 18, 2026 so you should expect the next rating to be made available sometime around June 18, 2027.
Is the Analyst Rating VolitionRX (VNRX) correct?
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a with a price target of $0.00 to $4.00. The current price VolitionRX (VNRX) is trading at is $1.46, which is within the analyst’s predicted range.
